ABSTRACT
In the United Kingdom, the Department of Health (DH) is the national pricing and reimbursement decision maker.1
The United Kingdom has three regional bodies responsible for providing guidance on the cost-effective use of medicines:
• England and Wales: The National Institute for Health and Care Excellence (NICE), which conducts appraisals and develops guidelines.
